Supplementary Tables S1-5 and Figure S1 from Analyses of 7,635 Patients with Colorectal Cancer Using Independent Training and Validation Cohorts Show That rs9929218 in CDH1 Is a Prognostic Marker of Survival

Supplementary Tables S1-5 and Figure S1. Supplementary Table S1 - Multivariate model of overall survival including known prognostic factors; Supplementary Table S2 - Univariate analyses of survival in our validation phase; Supplementary Table S3: Gene-dose effect for rs9929218; Supplementary Table S4 - Distribution of rs9929218 genotype by disease stage; Supplementary Table S5 - Univariate analysis of rs9929218 on overall survival according to COIN trial arm; Supplementary Figure S1 - The effect of rs9929218 on survival from the time of diagnosis to death.